Equities

Synairgen PLC

SNG:LSE

Synairgen PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)6.39
  • Today's Change0.15 / 2.40%
  • Shares traded49.69k
  • 1 Year change-29.00%
  • Beta-6.6314
Data delayed at least 20 minutes, as of May 02 2024 10:14 BST.
More ▼

Profile data is unavailable for this security.

About the company

Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company; Synairgen Inc. and Synairgen Research (Ireland) Limited. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.

  • Revenue in GBP (TTM)0.00
  • Net income in GBP-9.99m
  • Incorporated2004
  • Employees30.00
  • Location
    Synairgen PLCSouthampton General Hosp, Tremona RoadSOUTHAMPTON SO16 6YDUnited KingdomGBR
  • Phone+44 23 8051 2800Fax+44 23 8051 2800
  • Websitehttps://www.synairgen.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
ImmuPharma PLC69.96k-2.99m8.47m13.008.47m13.00
Cambridge Nutritional Sciences PLC9.05m-3.21m9.40m91.009.40m91.00
Bivictrix Therapeutics PLC0.00-2.33m9.49m10.009.49m10.00
Proteome Sciences plc5.03m-2.44m10.36m35.0010.36m35.00
Chill Brands Group PLC146.62k-3.64m11.14m2.0011.14m2.00
Kanabo Group PLC813.00k-4.66m11.70m20.0011.70m20.00
Abingdon Health PLC5.34m-2.24m12.17m82.0012.17m82.00
Synairgen plc0.00-9.99m12.57m30.0012.57m30.00
Incanthera PLC0.00-1.48m12.91m8.0012.91m8.00
Genincode PLC1.72m-6.73m13.05m28.0013.05m28.00
Shield Therapeutics PLC7.21m-46.89m13.69m28.0013.69m28.00
Provexis plc598.08k-496.59k14.71m2.0014.71m2.00
Destiny Pharma PLC0.00-5.66m17.39m20.0017.39m20.00
Oncimmune Holdings PLC1.15m-6.15m17.50m56.0017.50m56.00
Verici DX PLC15.17k-8.95m17.54m14.0017.54m14.00
OptiBiotix Health PLC689.10k-13.17m17.87m3.0017.87m3.00
Data as of May 02 2024. Currency figures normalised to Synairgen PLC's reporting currency: UK Pound GBX

Institutional shareholders

28.79%Per cent of shares held by top holders
HolderShares% Held
TFG Asset Management UK LLPas of 26 Apr 202356.70m28.15%
Toscafund Asset Management LLPas of 31 Dec 20221.28m0.64%
Premier Fund Managers Ltd.as of 30 Apr 20230.000.00%
Data from 30 Sep 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.